Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Re Agreement

8 Apr 2015 07:00

RNS Number : 5287J
Plant Health Care PLC
08 April 2015
 

8 April 2015

 

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Plant Health Care Signs First Innatus™ 3G Evaluation Agreement With Major Industry Player

 

Company Continues To ExpandR&D Resources 

 

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, is pleased to announce that it has signed an agreement with a major industry player in the agricultural space regarding the evaluation of its Innatus™ 3G peptide platform. This technology platform enables the design, production and screening of a large pipeline of peptides with diverse biostimulant properties. The peptides can be used for both seed treatment and foliar applications. They can also be combined with conventional crop protection chemicals, making them highly complementary to existing production practices.

 

 

Paul Schmidt, CEO of Plant Health Care, stated, "Over the past few months, we have been in active discussions with a number of major industry players that have the development and commercialization capabilities to exploit the full potential of our Innatus3G peptide platform. The response has been very positive and we are pleased to announce our first agreement arising from these discussions as we continue the dialogue with other major players."

 

While developing opportunities for its Innatus™ 3G peptide platform, Plant Health Care has continued to expand its research and development effort under the leadership of its Chief Scientific Officer, Dr. Zhongmin Wei. Over the past 18 months, the company added 4 research staff and, in 2015, plans to double its current researchpersonnel. In addition, by mid-year, the company will relocate to a larger research facility in Seattle with over three times the square footage of its existing lab. The expanded workspace, staff increase, and planned addition of new growth chambers are expected to significantly accelerate the company's ability to develop new peptide families.

 

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREALLXEDXSEFF
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Plant Health Care plc
20th Aug 202410:59 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 202410:17 amRNSScheme of Arrangement becomes Effective
20th Aug 20247:30 amRNSSuspension - Plant Health Care plc
16th Aug 202410:14 amRNSExercise of Options & Rule 2.9 Announcement
16th Aug 20249:13 amRNSForm 8.5 (EPT/NON-RI)
15th Aug 202412:44 pmRNSCourt sanction of the Scheme of Arrangement
7th Aug 20246:02 pmRNSForm 8.3 - Plant Health Care Plc
7th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
7th Aug 20249:08 amRNSForm 8.3 - Plant Health Care PLC
6th Aug 20243:08 pmRNSResult of Court Meeting and General Meeting
6th Aug 20241:54 pmRNSForm 8.3 - Plant Health Care plc
6th Aug 202412:45 pmRNSHolding(s) in Company
5th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
5th Aug 20241:39 pmRNSResults of Court Meeting and General Meeting
2nd Aug 20242:00 pmRNSForm 8.3 - Plant Health Care plc
2nd Aug 20248:25 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:33 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:03 amRNSForm 8.5 (EPT/NON-RI)
1st Aug 20248:46 amRNSForm 8.3 - PLANT HEALTH CARE PLC
31st Jul 202411:21 amRNSForm 8.3 - Plant Health Care Plc
29th Jul 20241:09 pmRNSHolding(s) in Company
29th Jul 20248:51 amRNSForm 8.3 - PLANT HEALTH CARE PLC
24th Jul 20247:00 amRNSExpanded Recommendations for OBRONA
23rd Jul 20249:20 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
22nd Jul 202411:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:36 pmRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:10 pmRNSForm 8.3 - Plant Health Care plc
18th Jul 20249:05 amRNSForm 8.5 (EPT/NON-RI)
17th Jul 20249:03 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
16th Jul 20242:48 pmRNSForm 8.3 - Plant Health Care plc
16th Jul 202410:01 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202411:25 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202410:58 amRNSForm 8.3 - Plant Health Care Plc
12th Jul 20241:36 pmRNSForm 8.3 - Plant Health Care PLC
11th Jul 20242:28 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20243:44 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20242:58 pmRNSPublication and posting of the Scheme Document
10th Jul 20242:03 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 202410:36 amRNSForm 8 (OPD) - Plant Health Care
9th Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
9th Jul 202410:19 amRNSForm 8.3 - Plant Health Care plc - Ospraie Ag
8th Jul 20242:00 pmRNSForm 8.3 - Plant Health Care plc
8th Jul 20241:56 pmRNSForm 8.3 - Plant Health Care Plc
4th Jul 20241:40 pmPRNForm 8.3 - Plant Health Care plc
4th Jul 202411:09 amRNSForm 8.3 - Plant Health Care PLC - Amendment
4th Jul 20248:34 amRNSForm 8.3 - Plant Health Care PLC
3rd Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:26 amRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:07 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.